These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1327502)

  • 21. Potentiation of diethylstilbestrol-induced alterations in the female mouse reproductive tract by transforming growth factor-alpha transgene expression.
    Gray K; Bullock B; Dickson R; Raszmann K; Walmer D; McLachlan J; Merlino G
    Mol Carcinog; 1996 Nov; 17(3):163-73. PubMed ID: 8944077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
    Factor VM; Jensen MR; Thorgeirsson SS
    Hepatology; 1997 Dec; 26(6):1434-43. PubMed ID: 9397983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice.
    Webber EM; Wu JC; Wang L; Merlino G; Fausto N
    Am J Pathol; 1994 Aug; 145(2):398-408. PubMed ID: 8053497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
    Geller SA; Nichols WS; Kim S; Tolmachoff T; Lee S; Dycaico MJ; Felts K; Sorge JA
    Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
    Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
    Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lens expression of TGF alpha in transgenic mice produces two distinct eye pathologies in the absence of tumors.
    Decsi A; Peiffer RL; Qiu T; Lee DC; Friday JT; Bautch VL
    Oncogene; 1994 Jul; 9(7):1965-75. PubMed ID: 8208543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
    Steinmetz KL; Klaunig JE
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cysts in transgenic mice expressing transforming growth factor-alpha.
    Lowden DA; Lindemann GW; Merlino G; Barash BD; Calvet JP; Gattone VH
    J Lab Clin Med; 1994 Sep; 124(3):386-94. PubMed ID: 8083581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor alpha: expression, regulation and biological action of its integral membrane precursor.
    Luetteke NC; Lee DC
    Semin Cancer Biol; 1990 Aug; 1(4):265-75. PubMed ID: 2103501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
    Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
    Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of epidermal growth factor-related proteins in the aged adult mouse mammary gland and their relationship to tumorigenesis.
    Herrington EE; Ram TG; Salomon DS; Johnson GR; Gullick WJ; Kenney N; Hosick HL
    J Cell Physiol; 1997 Jan; 170(1):47-56. PubMed ID: 9012784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-alpha accelerates hepatocyte repopulation after hepatocyte transplantation.
    Kosone T; Takagi H; Horiguchi N; Kakizaki S; Sato K; Watanabe Y; Mori M
    J Gastroenterol Hepatol; 2008 Feb; 23(2):260-6. PubMed ID: 17683499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
    Murakami H; Sanderson ND; Nagy P; Marino PA; Merlino G; Thorgeirsson SS
    Cancer Res; 1993 Apr; 53(8):1719-23. PubMed ID: 8467484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
    Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
    Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.